Rotavirus Inner Capsid VP6 Acts as an Adjuvant in Formulations with Particulate Antigens Only
Novel adjuvants present a concern for adverse effects, generating a need for alternatives. Rotavirus inner capsid VP6 protein could be considered a potential candidate, due to its ability to self-assemble into highly immunogenic nanospheres and nanotubes. These nanostructures exhibit immunostimulato...
Salvato in:
| Autori principali: | , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
MDPI AG
2020-07-01
|
| Serie: | Vaccines |
| Soggetti: | |
| Accesso online: | https://www.mdpi.com/2076-393X/8/3/365 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|